This re-distribution correlated with erythroid proliferation and reduced odds ratio score for the interaction of CD106+CD16/32–Ly6C+CD31+ and erythroblasts in lupus spleens (Table S3). This evidence concerns the gene PECAM1 and systemic lupus erythematosus.